Dear Doctor Letter (Rote-Hand-Brief) on Advagraf® 0.5 mg hard capsules (tacrolimus): Risk of increased blood levels of tacrolimus due to use of particular batches
2011.10.21
Active substance: tacrolimus
The pharmaceutical manufacturer issues information on the fact that there is a risk of higher levels of tacrolimus in the blood of patients taking Advagraf® 0.5 mg hard capsules due to quality defects detected in particular batches. The batches concerned are recalled from pharmacies and wholesalers.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN